Company: LNAI
Filing Date: 2025-12-03
Form Type: 424B5
Source: 0001731122-25-001626
Chunk: 40

Company: Lunai Bioworks Inc.
Filing Date: 2025-12-03
Form: 424B5
Chunk 40
---
 27, 2024, there were 161,717,342 shares of common stock issued and outstanding. The outstanding shares
of common stock are validly issued, fully paid and nonassessable.

Voting -- Each outstanding
share of Common Stock is entitled to one vote on all matters submitted to a vote of stockholders. There are no cumulative voting rights.

Dividends -- Each stockholder
is entitled to receive the dividends as may be declared by our board of directors out of funds legally available for dividends. Our board
of directors is not obligated to declare a dividend. Any future dividends will be subject to the discretion of our board of directors
and will depend upon, among other things, future earnings, the operating and financial condition of our Company, its capital requirements,
general business conditions and other pertinent factors.

Liquidation Rights -- Each
stockholder is entitled in the event of liquidation, to share pro rata in any distribution of our assets after payment of liabilities,
subject to the rights and preferences of the holders of any outstanding shares of any series of our preferred stock.

Other Matters -- Holders
of our common stock have no conversion, preemptive or other subscription rights, and there are no redemption rights or sinking fund provisions
with respect to the common stock. All of the issued and outstanding shares of common stock on the date of this report are validly issued,
fully paid and non-assessable.

Transfer Agent and Registrar

The transfer agent for our common
stock is Securities Transfer Corporation. The transfer agent’s address is 2901 N. Dallas Parkway, Suite 380, Plano, TX 75093.

Listing

Our Common Stock is listed on
the Nasdaq Capital Market under the symbol “RENB”.

<div align='center'>6

DESCRIPTION OF WARRANTS</div>

We may issue warrants for the
purchase of common stock. Warrants may be issued independently or together with any common stock and may be attached to or separate from
any offered securities. Each series of warrants will be issued under a separate warrant agreement to be entered into between a warrant
agent specified in the agreement and us. The warrant agent will act solely as our agent in connection with the warrants of that series
and will not assume any obligation or relationship of agency or trust for or with any holders or beneficial owners of warrants. This summary
of some provisions of the securities warrants is not complete. You should refer to the securities warrant agreement, including the forms
of securities warrant certificate representing the securities warrants, relating